Search for:
Home
About Us
Accessibility
Annual Reports
Conditions for Coverage
FAQs
Governance
Medical Review Board
QIRN 3 Required Postables
Staff Directory
Treatment Locations
Data
EQRS
Data Collection
CMS-2728
CMS-2744
CMS-2746
FAQs
Data Reporting
Annual Reports
National Data
Zip Code Reports
Dialysis Providers
5-Diamond Program
COVID-19
ESRD QIP
Goals and Recommendations
Involuntary Discharge
New Facilities
Patient and Family Engagement
Beyond Engagement (2018 - Current Archives)
Beyond Engagement 2020
En-GAGE (2014-2017 Archives)
Resources
Patient-Provider Conflict
Resources
Transplant Designee Hub
Vascular Access
Emergency Preparedness
How We Can Assist You
Report Facility Emergency Event
Ongoing Projects
Flu Vaccination Champions
QIA Newsletter
Reducing BSIs and LTCs
Home Dialysis QIA
Transplant QIA
Vocational Rehabilitation QIA
Beyond Engagement 2020
Patients and Families
COVID-19
Care Compare
End of Life Care
FAQs
Grievances
Medicare
Patient Advisory Committee
Patient Engagement Archives
Patient Education
Treatment Options
New Patient Materials
Nutrition
Patient Safety
Staying Active
Additional Resources
Life Changes
Patient-Focused LAN
Rights and Responsibilities
Vocational Rehabilitation
News
Newsletters
Archived Newsletters
Contact Us
Facility Reporting
Staff Directory
Newsletters
Archived Newsletters
2015 Recalls and Alerts
12/18/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Recall of Two Lots of IV Solutions due to Potential Presence of Particulate Matter
10/22/2015 - FDA Safety Alert: Kayexalate
Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Requires Drug Interaction Studies
9/21/2015 - US Compounding, Inc.
US Compounding, Inc. Issues Voluntary Nationwide Recall of All Sterile Compounded Products
9/9/2015 - Medistat RX, LLC
FDA Announces Medistat RX’s Nationwide Voluntary Recall of Sterile Drug Products
8/27/2015 - Insulet Corporation
Insulet Corporation Issues Voluntary Recall of OmniPod® Insulin Management System
7/30/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Nationwide Recall of One Lot of IV Solution Due to the Potential For Leaking Containers, Particulate Matter and Missing Port Protectors
7/17/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Recall Of Two Lots Of IV Solutions Due To The Potential Presence Of Particulate Matter
4/10/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Recall of Select Lots of IV Solutions Due to the Potential Presence of Particulate Matter
01/20/15 - Hospira, Inc.
Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter